Read + Share
Horimoto Y. Comment on 'An increase in tumor-infiltrating lymphocytes after treatment is
significantly associated with a poor response to neoadjuvant endocrine therapy
for estrogen receptor-positive/HER2-negative breast cancers' by Fukui et al. Breast Cancer 2024;31:154.
PMID: 37985622
|
 |
|
